Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Companion Diagnostics Revenue 1.4 Market Analysis by Type 1.4.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Polymerase Chain Reaction (PCR) 1.4.3 Immunohistochemistry (IHC) 1.4.4 In Situ Hybridization (ISH) 1.4.5 Next Generation Sequencing (NGS) 1.5 Market by Application 1.5.1 Global Companion Diagnostics Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Pharmaceutical Companies 1.5.4 Laboratories 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Companion Diagnostics Market Perspective (2015-2026) 2.2 Companion Diagnostics Growth Trends by Regions 2.2.1 Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Companion Diagnostics Historic Market Share by Regions (2015-2020) 2.2.3 Companion Diagnostics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Companion Diagnostics Market Growth Strategy 2.3.6 Primary Interviews with Key Companion Diagnostics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Companion Diagnostics Players by Market Size 3.1.1 Global Top Companion Diagnostics Players by Revenue (2015-2020) 3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2015-2020) 3.1.3 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Companion Diagnostics Market Concentration Ratio 3.2.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2019 3.3 Companion Diagnostics Key Players Head office and Area Served 3.4 Key Players Companion Diagnostics Product Solution and Service 3.5 Date of Enter into Companion Diagnostics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Companion Diagnostics Historic Market Size by Type (2015-2020) 4.2 Global Companion Diagnostics Forecasted Market Size by Type (2021-2026) 5 Companion Diagnostics Breakdown Data by Application (2015-2026) 5.1 Global Companion Diagnostics Market Size by Application (2015-2020) 5.2 Global Companion Diagnostics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Companion Diagnostics Market Size (2015-2020) 6.2 Companion Diagnostics Key Players in North America (2019-2020) 6.3 North America Companion Diagnostics Market Size by Type (2015-2020) 6.4 North America Companion Diagnostics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Companion Diagnostics Market Size (2015-2020) 7.2 Companion Diagnostics Key Players in Europe (2019-2020) 7.3 Europe Companion Diagnostics Market Size by Type (2015-2020) 7.4 Europe Companion Diagnostics Market Size by Application (2015-2020) 8 China 8.1 China Companion Diagnostics Market Size (2015-2020) 8.2 Companion Diagnostics Key Players in China (2019-2020) 8.3 China Companion Diagnostics Market Size by Type (2015-2020) 8.4 China Companion Diagnostics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Companion Diagnostics Market Size (2015-2020) 9.2 Companion Diagnostics Key Players in Japan (2019-2020) 9.3 Japan Companion Diagnostics Market Size by Type (2015-2020) 9.4 Japan Companion Diagnostics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Companion Diagnostics Market Size (2015-2020) 10.2 Companion Diagnostics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Companion Diagnostics Market Size by Type (2015-2020) 10.4 Southeast Asia Companion Diagnostics Market Size by Application (2015-2020) 11 India 11.1 India Companion Diagnostics Market Size (2015-2020) 11.2 Companion Diagnostics Key Players in India (2019-2020) 11.3 India Companion Diagnostics Market Size by Type (2015-2020) 11.4 India Companion Diagnostics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Companion Diagnostics Market Size (2015-2020) 12.2 Companion Diagnostics Key Players in Central & South America (2019-2020) 12.3 Central & South America Companion Diagnostics Market Size by Type (2015-2020) 12.4 Central & South America Companion Diagnostics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Roche Holdings 13.1.1 Roche Holdings Company Details 13.1.2 Roche Holdings Business Overview and Its Total Revenue 13.1.3 Roche Holdings Companion Diagnostics Introduction 13.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2015-2020)) 13.1.5 Roche Holdings Recent Development 13.2 Abbott Laboratories 13.2.1 Abbott Laboratories Company Details 13.2.2 Abbott Laboratories Business Overview and Its Total Revenue 13.2.3 Abbott Laboratories Companion Diagnostics Introduction 13.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020) 13.2.5 Abbott Laboratories Recent Development 13.3 Thermo Fisher Scientific 13.3.1 Thermo Fisher Scientific Company Details 13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue 13.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction 13.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020) 13.3.5 Thermo Fisher Scientific Recent Development 13.4 Agilent Technologies 13.4.1 Agilent Technologies Company Details 13.4.2 Agilent Technologies Business Overview and Its Total Revenue 13.4.3 Agilent Technologies Companion Diagnostics Introduction 13.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020) 13.4.5 Agilent Technologies Recent Development 13.5 Life Technologies 13.5.1 Life Technologies Company Details 13.5.2 Life Technologies Business Overview and Its Total Revenue 13.5.3 Life Technologies Companion Diagnostics Introduction 13.5.4 Life Technologies Revenue in Companion Diagnostics Business (2015-2020) 13.5.5 Life Technologies Recent Development 13.6 GE Healthcare 13.6.1 GE Healthcare Company Details 13.6.2 GE Healthcare Business Overview and Its Total Revenue 13.6.3 GE Healthcare Companion Diagnostics Introduction 13.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2015-2020) 13.6.5 GE Healthcare Recent Development 13.7 Agendia 13.7.1 Agendia Company Details 13.7.2 Agendia Business Overview and Its Total Revenue 13.7.3 Agendia Companion Diagnostics Introduction 13.7.4 Agendia Revenue in Companion Diagnostics Business (2015-2020) 13.7.5 Agendia Recent Development 13.8 Qiagen 13.8.1 Qiagen Company Details 13.8.2 Qiagen Business Overview and Its Total Revenue 13.8.3 Qiagen Companion Diagnostics Introduction 13.8.4 Qiagen Revenue in Companion Diagnostics Business (2015-2020) 13.8.5 Qiagen Recent Development 13.9 Genomic Health 13.9.1 Genomic Health Company Details 13.9.2 Genomic Health Business Overview and Its Total Revenue 13.9.3 Genomic Health Companion Diagnostics Introduction 13.9.4 Genomic Health Revenue in Companion Diagnostics Business (2015-2020) 13.9.5 Genomic Health Recent Development 13.10 Myriad Genetics 13.10.1 Myriad Genetics Company Details 13.10.2 Myriad Genetics Business Overview and Its Total Revenue 13.10.3 Myriad Genetics Companion Diagnostics Introduction 13.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020) 13.10.5 Myriad Genetics Recent Development 13.11 Advanced Cell Diagnostics 10.11.1 Advanced Cell Diagnostics Company Details 10.11.2 Advanced Cell Diagnostics Business Overview and Its Total Revenue 10.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction 10.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020) 10.11.5 Advanced Cell Diagnostics Recent Development 13.12 Danaher 10.12.1 Danaher Company Details 10.12.2 Danaher Business Overview and Its Total Revenue 10.12.3 Danaher Companion Diagnostics Introduction 10.12.4 Danaher Revenue in Companion Diagnostics Business (2015-2020) 10.12.5 Danaher Recent Development 13.13 Applied Proteomics 10.13.1 Applied Proteomics Company Details 10.13.2 Applied Proteomics Business Overview and Its Total Revenue 10.13.3 Applied Proteomics Companion Diagnostics Introduction 10.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020) 10.13.5 Applied Proteomics Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Companion Diagnostics Key Market Segments Table 2. Key Players Covered: Ranking by Companion Diagnostics Revenue Table 3. Ranking of Global Top Companion Diagnostics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Polymerase Chain Reaction (PCR) Table 6. Key Players of Immunohistochemistry (IHC) Table 7. Key Players of In Situ Hybridization (ISH) Table 8. Key Players of Next Generation Sequencing (NGS) Table 9. Global Companion Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Companion Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Companion Diagnostics Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Companion Diagnostics Market Share by Regions (2015-2020) Table 13. Global Companion Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Companion Diagnostics Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Companion Diagnostics Market Growth Strategy Table 19. Main Points Interviewed from Key Companion Diagnostics Players Table 20. Global Companion Diagnostics Revenue by Players (2015-2020) (Million US$) Table 21. Global Companion Diagnostics Market Share by Players (2015-2020) Table 22. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostics as of 2019) Table 23. Global Companion Diagnostics by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Companion Diagnostics Product Solution and Service Table 26. Date of Enter into Companion Diagnostics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 29. Global Companion Diagnostics Market Size Share by Type (2015-2020) Table 30. Global Companion Diagnostics Revenue Market Share by Type (2021-2026) Table 31. Global Companion Diagnostics Market Size Share by Application (2015-2020) Table 32. Global Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 33. Global Companion Diagnostics Market Size Share by Application (2021-2026) Table 34. North America Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 35. North America Key Players Companion Diagnostics Market Share (2019-2020) Table 36. North America Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 37. North America Companion Diagnostics Market Share by Type (2015-2020) Table 38. North America Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 39. North America Companion Diagnostics Market Share by Application (2015-2020) Table 40. Europe Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Companion Diagnostics Market Share (2019-2020) Table 42. Europe Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 43. Europe Companion Diagnostics Market Share by Type (2015-2020) Table 44. Europe Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 45. Europe Companion Diagnostics Market Share by Application (2015-2020) Table 46. China Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 47. China Key Players Companion Diagnostics Market Share (2019-2020) Table 48. China Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 49. China Companion Diagnostics Market Share by Type (2015-2020) Table 50. China Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 51. China Companion Diagnostics Market Share by Application (2015-2020) Table 52. Japan Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Companion Diagnostics Market Share (2019-2020) Table 54. Japan Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 55. Japan Companion Diagnostics Market Share by Type (2015-2020) Table 56. Japan Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 57. Japan Companion Diagnostics Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Companion Diagnostics Market Share (2019-2020) Table 60. Southeast Asia Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Companion Diagnostics Market Share by Type (2015-2020) Table 62. Southeast Asia Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Companion Diagnostics Market Share by Application (2015-2020) Table 64. India Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 65. India Key Players Companion Diagnostics Market Share (2019-2020) Table 66. India Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 67. India Companion Diagnostics Market Share by Type (2015-2020) Table 68. India Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 69. India Companion Diagnostics Market Share by Application (2015-2020) Table 70. Central & South America Key Players Companion Diagnostics Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Companion Diagnostics Market Share (2019-2020) Table 72. Central & South America Companion Diagnostics Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Companion Diagnostics Market Share by Type (2015-2020) Table 74. Central & South America Companion Diagnostics Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Companion Diagnostics Market Share by Application (2015-2020) Table 76. Roche Holdings Company Details Table 77. Roche Holdings Business Overview Table 78. Roche Holdings Product Table 79. Roche Holdings Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 80. Roche Holdings Recent Development Table 81. Abbott Laboratories Company Details Table 82. Abbott Laboratories Business Overview Table 83. Abbott Laboratories Product Table 84. Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 85. Abbott Laboratories Recent Development Table 86. Thermo Fisher Scientific Company Details Table 87. Thermo Fisher Scientific Business Overview Table 88. Thermo Fisher Scientific Product Table 89. Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 90. Thermo Fisher Scientific Recent Development Table 91. Agilent Technologies Company Details Table 92. Agilent Technologies Business Overview Table 93. Agilent Technologies Product Table 94. Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 95. Agilent Technologies Recent Development Table 96. Life Technologies Company Details Table 97. Life Technologies Business Overview Table 98. Life Technologies Product Table 99. Life Technologies Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 100. Life Technologies Recent Development Table 101. GE Healthcare Company Details Table 102. GE Healthcare Business Overview Table 103. GE Healthcare Product Table 104. GE Healthcare Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 105. GE Healthcare Recent Development Table 106. Agendia Company Details Table 107. Agendia Business Overview Table 108. Agendia Product Table 109. Agendia Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 110. Agendia Recent Development Table 111. Qiagen Business Overview Table 112. Qiagen Product Table 113. Qiagen Company Details Table 114. Qiagen Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 115. Qiagen Recent Development Table 116. Genomic Health Company Details Table 117. Genomic Health Business Overview Table 118. Genomic Health Product Table 119. Genomic Health Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 120. Genomic Health Recent Development Table 121. Myriad Genetics Company Details Table 122. Myriad Genetics Business Overview Table 123. Myriad Genetics Product Table 124. Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 125. Myriad Genetics Recent Development Table 126. Advanced Cell Diagnostics Company Details Table 127. Advanced Cell Diagnostics Business Overview Table 128. Advanced Cell Diagnostics Product Table 129. Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 130. Advanced Cell Diagnostics Recent Development Table 131. Danaher Company Details Table 132. Danaher Business Overview Table 133. Danaher Product Table 134. Danaher Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 135. Danaher Recent Development Table 136. Applied Proteomics Company Details Table 137. Applied Proteomics Business Overview Table 138. Applied Proteomics Product Table 139. Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020) (Million US$) Table 140. Applied Proteomics Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Companion Diagnostics Market Share by Type: 2020 VS 2026 Figure 2. Polymerase Chain Reaction (PCR) Features Figure 3. Immunohistochemistry (IHC) Features Figure 4. In Situ Hybridization (ISH) Features Figure 5. Next Generation Sequencing (NGS) Features Figure 6. Global Companion Diagnostics Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Case Studies Figure 8. Pharmaceutical Companies Case Studies Figure 9. Laboratories Case Studies Figure 10. Other Case Studies Figure 11. Companion Diagnostics Report Years Considered Figure 12. Global Companion Diagnostics Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Companion Diagnostics Market Share by Regions: 2020 VS 2026 Figure 14. Global Companion Diagnostics Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Companion Diagnostics Market Share by Players in 2019 Figure 17. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostics as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostics Revenue in 2019 Figure 19. North America Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Roche Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Roche Holdings Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 28. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Abbott Laboratories Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 30. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 32. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Agilent Technologies Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 34. Life Technologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Life Technologies Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 36. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. GE Healthcare Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 38. Agendia Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Agendia Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 40. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Qiagen Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 42. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Genomic Health Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 44. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Myriad Genetics Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 46. Advanced Cell Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 48. Danaher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Danaher Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 50. Applied Proteomics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Applied Proteomics Revenue Growth Rate in Companion Diagnostics Business (2015-2020) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Roche Holdings Abbott Laboratories Thermo Fisher Scientific Agilent Technologies Life Technologies GE Healthcare Agendia Qiagen Genomic Health Myriad Genetics Advanced Cell Diagnostics Danaher Applied Proteomics